DiaSorin S.p.A. (OTCMKTS:DSRLF – Get Free Report) was the target of a significant drop in short interest in July. As of July 15th, there was short interest totalling 312,900 shares, a drop of 35.7% from the June 30th total of 486,900 shares. Based on an average trading volume of 0 shares, the short-interest ratio is currently ∞ days.
Wall Street Analyst Weigh In
Separately, Barclays started coverage on shares of DiaSorin in a report on Thursday, May 9th. They issued an “equal weight” rating for the company.
View Our Latest Stock Analysis on DSRLF
DiaSorin Stock Performance
DiaSorin Company Profile
DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS.
Featured Articles
- Five stocks we like better than DiaSorin
- What is an Earnings Surprise?
- Kimberly-Clark Stock Dips and a Buying Opportunity Emerges
- The Most Important Warren Buffett Stock for Investors: His Own
- Leading Gold Stock Shines With Q2 2024 Earnings Release
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Pharma Giant’s Shares Up After Impressive Q2 Earnings Release
Receive News & Ratings for DiaSorin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DiaSorin and related companies with MarketBeat.com's FREE daily email newsletter.